
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.
Title Accounts Payable Specialist (Coupa) Contract
Reports to Sr. Director, Accounting
Location Remote (West coast hours preferred)
Duration Through December 2026 with potential extension based on business needs
Hours 40/hrs per week
Hourly rate $40-45/hr
Kyverna is seeking a detail-oriented and highly organized Accounts Payable Specialist to join our Finance team. The ideal candidate will have strong experience working within the Coupa Procure-to-Pay (P2P) platform, partnering closely with internal and external stakeholders to resolve invoice discrepancies, maintain compliance with company policies, and support month-end close activities. Experience in a high-growth, publicly traded, or biotechnology/pharmaceutical environment is preferred.
Required Qualifications
Preferred Qualifications

Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our lead product candidate, KYV-101 is advancing through clinical development across two broad areas of autoimmune disease: rheumatology and neurology, including Phase 2 trials for stiff-person syndrome, multiple sclerosis and myasthenia gravis, a Phase 1/2 trial for systemic sclerosis, and two ongoing multi-center, open-label Phase 1/2 trials in the United States and Germany for patients with lupus nephritis.
Kyverna’s pipeline includes next-generation chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases.